@yoursocialbffsteph's semaglutide restart, fact-checked

What does this video actually claim?

Stephanie Ann is restarting semaglutide treatment for weight loss. She doesn't make specific medical claims in the brief caption, but she's promoting the drug through hashtags about compound semaglutide and weight loss support.

The video sits in that common TikTok space where creators share their medication journey without making explicit claims. But the hashtags tell a story: she's using compounded semaglutide specifically for weight management.

This type of content typically encourages viewers to consider similar treatment. While she's not giving dosing advice or making promises, the implicit message is that semaglutide works for weight loss.

Does compound semaglutide work like brand name versions?

Here's where things get complicated. The STEP trials that proved semaglutide's effectiveness used Novo Nordisk's branded versions (Ozempic at 1mg, Wegovy at 2.4mg). These studies showed 14.9% body weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021).

Compounded versions contain the same active ingredient but aren't FDA-approved as complete products. They're made by specialty pharmacies under different quality controls.

The FDA has warned about quality issues with some compounded GLP-1 drugs, including dosing errors and contamination. While the peptide itself should work the same way, you're getting a different product than what was tested in clinical trials.

Why do people restart semaglutide?

Stephanie says she's restarting, which suggests she stopped previously. This happens for several reasons: side effects, cost, or reaching a weight plateau.

The SELECT trial (Lincoff et al., NEJM, 2023) showed that people who stop semaglutide typically regain about two-thirds of their lost weight within a year. This isn't a failure of willpower. It's how the drug works.

Semaglutide slows gastric emptying and affects hunger hormones like GLP-1. When you stop, these effects fade. Your appetite returns to baseline, often leading to weight regain.

What's the deal with compound semaglutide availability?

Compounded semaglutide exists because of drug shortages, not because it's a better option. The FDA allows compounding when brand name drugs are in short supply.

Novo Nordisk has been struggling to meet demand for Wegovy and Ozempic since 2021. This created a legitimate shortage that allowed compounding pharmacies to make their own versions.

But shortages change. When Wegovy or Ozempic return to normal supply levels, the FDA can restrict compounded versions. People using compound semaglutide might need to switch to brand name drugs or stop treatment entirely.

What should you actually know about restarting semaglutide?

If you restart semaglutide after a break, you typically need to go through the dose escalation again. Most protocols start at 0.25mg weekly and increase gradually to minimize nausea and other GI side effects.

Jumping back to your previous dose after stopping can cause significant nausea, vomiting, and diarrhea. The STEP trials used careful dose escalation for good reason.

Cost matters here too. Compounded semaglutide often costs $200-400 monthly, while brand name versions can hit $1,200+ without insurance. If you're restarting, factor in the long-term financial commitment since stopping leads to weight regain.